v3.26.1
EQUITY-BASED COMPENSATION - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based payment arrangement, expense $ 5,136 $ 4,879 $ 14,933 $ 12,030  
Weighted-average grant date fair value (in USD per share)     $ 12.41    
Outstanding at end of period (in shares) 8,790,566   8,790,566   7,881,236
Options exercisable at end of period (in shares) 6,765,894   6,765,894    
Unrecognized compensation expense related to unvested options at end of period $ 18,042   $ 18,042    
Fair value of stock options that vested 187   5,024    
Employee Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based payment arrangement, expense 2,414 1,610 $ 5,615 5,435  
Period for recognition of unrecognized compensation cost (in years)     3 years 4 months 24 days    
Restricted stock units          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based payment arrangement, expense $ 2,722 3,269 $ 9,318 6,595  
Period for recognition of unrecognized compensation cost (in years)     2 years 6 months    
Granted (in USD per share) $ 24.01   $ 24.01    
Cost not yet recognized, amount $ 18,210   $ 18,210    
Vested in period, fair value $ 455   $ 10,148    
Discontinued Operations, Held-for-Sale or Disposed of by Sale | Healthcare RCM Business          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based payment arrangement, expense   $ 2,517   $ 3,112